Callicutt Jack W Insider Trades

Insider Trading History

Track insider trading activity for Callicutt Jack W. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $155k 65,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$198k 65,000 shares
$3.04
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $238k 100,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$304k 100,000 shares
$3.04
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $18.1k 7,614 shares
Last Trade
Jan 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$74.7k 20,354 shares
$3.67
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $66.6k 27,968 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$100k 25,732 shares
$3.90
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $128k 53,700 shares
Last Trade
Jan 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$58.4k 13,914 shares
$4.20
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $161k 67,614 shares
Last Trade
Jan 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$243k 60,000 shares
$4.05
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$250k 60,000 shares
$4.16
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $85k 35,714 shares
Last Trade
Nov 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$174k 28,100 shares
$6.19
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $61.5k 25,824 shares
Last Trade
Nov 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$113k 18,210 shares
$6.19
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $66.9k 28,120 shares
Last Trade
Nov 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$57.5k 9,586 shares
$6.00
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $43.3k 18,190 shares
Last Trade
Nov 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$118k 19,701 shares
$6.00
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $40.9k 17,200 shares
Last Trade
Nov 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$57.5k 9,586 shares
$6.00
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $116k 48,750 shares
Last Trade
Nov 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.9k 2,323 shares
$6.00
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $65k 27,315 shares
Last Trade
Nov 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$118k 19,701 shares
$6.00
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $23.7k 9,937 shares
Last Trade
Nov 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.9k 2,323 shares
$6.00
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $89.7k 37,706 shares
Last Trade
Nov 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.8k 1,880 shares
$5.22
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $18.1k 7,614 shares
Last Trade
Nov 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.74k 1,675 shares
$5.22
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $18.1k 7,614 shares
Last Trade
Nov 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.05k 1,736 shares
$5.22
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $90.2k 37,891 shares
Last Trade
Nov 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.74k 1,675 shares
$5.22
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $18.1k 7,614 shares
Last Trade
Nov 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.8k 1,880 shares
$5.22
$2.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up